tiprankstipranks
Evommune, Inc. (EVMN)
NYSE:EVMN
US Market
EVMN
Evommune, Inc.
RESEARCH TOOLSreports
Want to see EVMN full AI Analyst Report?

Evommune, Inc. (EVMN) Income Statement

101 Followers

Evommune, Inc. Income Statement

Last quarter (Q4 2025), Evommune, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Evommune, Inc.'s net income was $-28.27M. See Evommune, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23
Total Revenue
$ 13.00M$ 7.00M$ 5.00M
Gross Profit
$ 11.61M$ 5.71M$ 4.00M
Operating Expenses
$ 92.68M$ 75.73M$ 41.85M
Depreciation and Amortization
$ 1.39M$ 1.29M$ 1.00M
EBITDA
$ -79.68M$ -65.49M$ -32.99M
Operating Income
$ -81.07M$ -70.01M$ -37.85M
Other Income/Expenses
$ 12.20M$ 3.20M$ 3.80M
Pretax Income
$ -68.87M$ -66.81M$ -34.05M
Net Income
$ -68.87M$ -66.81M$ -34.05M
Per Share Metrics
Basic EPS
$ -2.18$ -2.27$ -1.13
Diluted EPS
$ -2.18$ -2.27$ -1.13
Weighted Average Shares Outstanding
 31.52M 30.08M 30.08M
Weighted Average Shares Outstanding (Diluted)
 31.52M 30.08M 30.08M
Currency in USD

Evommune, Inc. Earnings and Revenue History